The introduction of intracytoplasmic sperm injection (ICSI) provides n
ew hope for many couples suffering from the most untreatable forms of
male infertility as ICSI can also be successfully pet-formed using epi
didymal or testicular spermatozoa. Testicular spermatozoa may be recov
ered from testicular tissue in every patient with excretory azoospermi
a, but also in about half of patients with secretory azoospermia. The
strongest parameter to predict successful testicular sperm recovery is
histopathological examination of a testicular biopsy, especially in p
atients with some form of germ-cell aplasia. Even in our series of Kli
nefelter patients, testicular sperm were recovered in eight out of 15
patients and after seven ICSI cycles combined with preimplantation dia
gnosis, two singletons were born. Less invasive techniques such as per
cutaneous fine-needle aspiration have been introduced and may yield co
mparable success rates in patients with normal testicular function. Th
e high fertilization rates after testicular sperm recovery and ICSI an
d the favourable implantation rates may therefore render microsurgical
epididymal sperm aspiration (MESA) obsolete in the future for patient
s with normal spermatogenesis. Besides, the use of cryopreserved testi
cular spermatozoa may become an alternative to repeated surgery for ob
taining testicular tissue for subsequent ICSI treatment cycles.